It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
We evaluate the shared genetic regulation of mRNA molecules, proteins and metabolites derived from whole blood from 3029 human donors. We find abundant allelic heterogeneity, where multiple variants regulate a particular molecular phenotype, and pleiotropy, where a single variant associates with multiple molecular phenotypes over multiple genomic regions. The highest proportion of share genetic regulation is detected between gene expression and proteins (66.6%), with a further median shared genetic associations across 49 different tissues of 78.3% and 62.4% between plasma proteins and gene expression. We represent the genetic and molecular associations in networks including 2828 known GWAS variants, showing that GWAS variants are more often connected to gene expression in trans than other molecular phenotypes in the network. Our work provides a roadmap to understanding molecular networks and deriving the underlying mechanism of action of GWAS variants using different molecular phenotypes in an accessible tissue.
Many genetic variants have been associated with human traits, but the mechanism is often unknown. Here, the authors integrate local and distal genetic associations with multi-omics datasets to provide a roadmap to understand the underlying mechanisms of GWAS variants on complex traits.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

























1 University of Dundee, Population Health and Genomics, Ninewells Hospital and Medical School, Dundee, United Kingdom (GRID:grid.8241.f) (ISNI:0000 0004 0397 2876)
2 University of Oxford, Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
3 KTH - Royal Institute of Technology, Science for Life Laboratory, School of Biotechnology, Solna, Sweden (GRID:grid.5037.1) (ISNI:0000000121581746)
4 Technical University of Denmark, Department of Health Technology, Kongens Lyngby, Denmark (GRID:grid.5170.3) (ISNI:0000 0001 2181 8870); University of Copenhagen, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X)
5 University of Oxford, Oxford Centre for Diabetes Endocrinology and Metabolism, Oxford, United Kingdom (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
6 University of Geneva Medical School, Department of Genetic Medicine and Development, Geneva, Switzerland (GRID:grid.8591.5) (ISNI:0000 0001 2175 2154); University of Geneva, Institute for Genetics and Genomics in Geneva (iGE3), Geneva, Switzerland (GRID:grid.8591.5) (ISNI:0000 0001 2175 2154); Swiss Institute of Bioinformatics, Geneva, Switzerland (GRID:grid.419765.8) (ISNI:0000 0001 2223 3006)
7 University of Newcastle, Biosciences Institute, Faculty of Medical Sciences, Newcastle upon Tyne, United Kingdom (GRID:grid.1006.7) (ISNI:0000 0001 0462 7212)
8 German Center for Diabetes Research (DZD), Neuherberg, Germany (GRID:grid.452622.5); German Research Center for Environmental Health, Helmholtz Zentrum München, Research Unit of Molecular Epidemiology, Institute of Epidemiology, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525)
9 University of Copenhagen, The Novo Nordisk Center for Basic Metabolic Research, Faculty of Health and Medical Science, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X)
10 University of Lille, Inserm, Lille Pasteur Institute, Lille, France (GRID:grid.503422.2) (ISNI:0000 0001 2242 6780)
11 University of Eastern Finland, Internal Medicine, Institute of Clinical Medicine, Kuopio, Finland (GRID:grid.9668.1) (ISNI:0000 0001 0726 2490)
12 Technical University of Denmark, Department of Health Technology, Kongens Lyngby, Denmark (GRID:grid.5170.3) (ISNI:0000 0001 2181 8870)
13 Amsterdam Public Health research institute, Department of General Practice, Amsterdam UMC- location Vumc, Amsterdam, The Netherlands (GRID:grid.16872.3a) (ISNI:0000 0004 0435 165X)
14 Lund University Diabetes Centre, Department of Clinical Science, Genetic and Molecular Epidemiology, Malmö, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361)
15 German Research Center for Environmental Health, Helmholtz Zentrum München, Metabolomics and Proteomics Core, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525)
16 University of Exeter College of Medicine & Health, Department of Clinical and Biomedical Sciences, Exeter, United Kingdom (GRID:grid.8391.3) (ISNI:0000 0004 1936 8024)
17 Newcastle University, Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle upon Tyne, United Kingdom (GRID:grid.1006.7) (ISNI:0000 0001 0462 7212)
18 National Research Council, Institute of Neuroscience, Padova, Italy (GRID:grid.5326.2) (ISNI:0000 0001 1940 4177)
19 Royal Devon and Exeter NHS Foundation Trust, Blood Sciences, Exeter, United Kingdom (GRID:grid.419309.6) (ISNI:0000 0004 0495 6261)
20 Royal Victoria Infirmary, Diabetes Research Network, Newcastle upon Tyne, United Kingdom (GRID:grid.419334.8) (ISNI:0000 0004 0641 3236)
21 University of Oxford, Nuffield Department of Population Health, Centre for Health, Law and Emerging Technologies (HeLEX), Oxford, United Kingdom (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
22 Hoechst Industrial Park, Global Development, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany (GRID:grid.420214.1)
23 Lund University, Department of Clinical Science, Malmö, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361)
24 Epidemiology and Data Science, VUMC, Amsterdam, The Netherlands (GRID:grid.16872.3a) (ISNI:0000 0004 0435 165X)
25 German Research Center for Environmental Health, Helmholtz Zentrum München, Research Unit of Molecular Epidemiology, Institute of Epidemiology, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); Technical University of Munich, Food Chemistry and Molecular and Sensory Science, München, Germany (GRID:grid.6936.a) (ISNI:0000 0001 2322 2966)
26 University of Oxford, Centre for Health Law and Emerging Technologies, Department of Population Health, Oxford, United Kingdom (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
27 Epidemiology and Data Science, VUMC, Amsterdam, The Netherlands (GRID:grid.16872.3a) (ISNI:0000 0004 0435 165X); Leiden University Medical Center, Department of Cell and Chemical Biology, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000 0000 8945 2978); Leiden University Medical Center, Department of Biomedical Data Sciences, Molecular Epidemiology section, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000 0000 8945 2978)
28 University of Copenhagen, The Novo Nordisk Center for Basic Metabolic Research, Faculty of Health and Medical Science, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); Steno Diabetes Center Copenhagen, Copenhagen, Denmark (GRID:grid.419658.7) (ISNI:0000 0004 0646 7285)
29 Imperial College London, Nutrition and Dietetics Research Group, London, United Kingdom (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
30 Sanofi Partnering, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany (GRID:grid.420214.1)
31 University of Oxford, Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); GENENTECH, 1 DNA Way, San Francisco, USA (GRID:grid.4991.5) (ISNI:0000 0004 5899 3818)
32 Eli Lilly Regional Operations Ges.m.b.H, Vienna, Austria (GRID:grid.518623.b) (ISNI:0000 0004 0533 8721)
33 Herlev and Gentofte University Hospital, Center for Clinical Metabolic Research, Copenhagen, Denmark (GRID:grid.411646.0) (ISNI:0000 0004 0646 7402); University of Copenhagen, Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X)
34 University of Newcastle, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle upon Tyne, United Kingdom (GRID:grid.1006.7) (ISNI:0000 0001 0462 7212)
35 Eli Lilly and Company, Lilly Research Laboratories, Indianapolis, USA (GRID:grid.417540.3) (ISNI:0000 0000 2220 2544)
36 German Research Center for Environmental Health, Helmholtz Zentrum München, Research Unit of Molecular Epidemiology, Institute of Epidemiology, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525)
37 University of Oxford, Oxford Centre for Diabetes Endocrinology and Metabolism, Oxford, United Kingdom (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Lund University Diabetes Centre, Department of Clinical Science, Genetic and Molecular Epidemiology, Malmö, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361)
38 Institut de Recherches Internationales Servier, Translational & Clinical Research, Metabolism Innovation Pole, Croissy sur Seine, France (GRID:grid.418301.f) (ISNI:0000 0001 2163 3905)
39 University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom (GRID:grid.8241.f) (ISNI:0000 0004 0397 2876)
40 Boehringer Ingelheim International GmbH, Translational Medicine & Clinical Pharmacology, Biberach an der Riss, Germany (GRID:grid.420061.1) (ISNI:0000 0001 2171 7500)
41 University of Westminster, Research Centre for Optimal Health, School of Life Sciences, London, United Kingdom (GRID:grid.12896.34) (ISNI:0000 0000 9046 8598)
42 Boehringer Ingelheim International GmbH, Therapeutic Area CardioMetabolism and Respiratory Medicine, Biberach an der Riss, Germany (GRID:grid.420061.1) (ISNI:0000 0001 2171 7500)
43 University of Dundee, Clinical Research Centre, Ninewells Hospital and Medical School, Dundee, United Kingdom (GRID:grid.8241.f) (ISNI:0000 0004 0397 2876)
44 Leiden University Medical Center, Department of Cell and Chemical Biology, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000 0000 8945 2978)
45 Saarland University, Clinical Pharmacy, Saarbrücken, Germany (GRID:grid.11749.3a) (ISNI:0000 0001 2167 7588)
46 University of Bath, Department of Mathematical Sciences, Bath, United Kingdom (GRID:grid.7340.0) (ISNI:0000 0001 2162 1699)
47 Imperial College London, Department of Metabolism, Digestion and Reproduction, London, United Kingdom (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); Centre for Genomic Regulation, Regulatory genomics and diabetes, Barcelona, Spain (GRID:grid.11478.3b)
48 Medizinische Universitätsklinik Tübingen, Eberhard Karls Universität Tübingen, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)
49 Boehringer Ingelheim International GmbH, Medicine Therapeutic Area Metabolism 1, Biberach an der Riss, Germany (GRID:grid.420061.1) (ISNI:0000 0001 2171 7500)
50 Lund University, Department of Clinical Sciences, Diabetes & Endocrinology Unit, Malmö, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361)
51 University of Copenhagen, Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X)
52 Boehringer Ingelheim International GmbH, Biberach an der Riss, Germany (GRID:grid.420061.1) (ISNI:0000 0001 2171 7500)
53 Royal Devon and Exeter NHS Foundation Trust, NIHR Exeter Clinical Research Facility, Exeter, United Kingdom (GRID:grid.419309.6) (ISNI:0000 0004 0495 6261)
54 University of Ulm, Institute for Epidemiology and medical Biometry, Ulm, Germany (GRID:grid.6582.9) (ISNI:0000 0004 1936 9748)
55 University of Dundee, The Immunoassay Biomarker Core laboratory, School of Medicine, Dundee, United Kingdom (GRID:grid.8241.f) (ISNI:0000 0004 0397 2876)
56 University of Lund, VO Endokrinologi, Enheten för diabetesstudier, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361)
57 University of Eastern Finland, Institute of Biomedicine, Bioinformatics Center, Kuopio, Finland (GRID:grid.9668.1) (ISNI:0000 0001 0726 2490)
58 Lilly Deutschland GmbH, Bad Homburg, Germany (GRID:grid.435900.b) (ISNI:0000 0004 0533 9169)
59 University of Geneva Medical School, Department of Genetic Medicine and Development, Geneva, Switzerland (GRID:grid.8591.5) (ISNI:0000 0001 2175 2154)
60 Institut de Recherches Internationales Servier, Biotech & Biomarkers Research Department, Croissy sur Seine, France (GRID:grid.418301.f) (ISNI:0000 0001 2163 3905)
61 National University of Singapore, Department of Biochemistry, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); German Research Center for Environmental Health, Helmholtz Zentrum München, Institute of Experimental Genetics, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); University of Ljubljana, Institute of Biochemistry, Faculty of Medicine, Ljubljana, Slovenia (GRID:grid.8954.0) (ISNI:0000 0001 0721 6013)